ATE496031T1 - ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR - Google Patents

ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR

Info

Publication number
ATE496031T1
ATE496031T1 AT07728098T AT07728098T ATE496031T1 AT E496031 T1 ATE496031 T1 AT E496031T1 AT 07728098 T AT07728098 T AT 07728098T AT 07728098 T AT07728098 T AT 07728098T AT E496031 T1 ATE496031 T1 AT E496031T1
Authority
AT
Austria
Prior art keywords
treatment
dopamine
receptor
modulation
compounds suitable
Prior art date
Application number
AT07728098T
Other languages
German (de)
Inventor
Roland Grandel
Wilfried Martin Braje
Andreas Haupt
Sean Colm Turner
Udo Lange
Karla Drescher
Liliane Unger
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Priority claimed from PCT/EP2007/053633 external-priority patent/WO2007118859A1/en
Application granted granted Critical
Publication of ATE496031T1 publication Critical patent/ATE496031T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The present invention relates to aryloxyethylamine compounds of the formula (I) and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula (I) or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
AT07728098T 2006-04-14 2007-04-13 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR ATE496031T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06007923 2006-04-14
US79367106P 2006-04-20 2006-04-20
PCT/EP2007/053633 WO2007118859A1 (en) 2006-04-14 2007-04-13 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor

Publications (1)

Publication Number Publication Date
ATE496031T1 true ATE496031T1 (en) 2011-02-15

Family

ID=40631425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07728098T ATE496031T1 (en) 2006-04-14 2007-04-13 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR

Country Status (6)

Country Link
CN (1) CN101421243B (en)
AT (1) ATE496031T1 (en)
DE (1) DE602007012071D1 (en)
ES (1) ES2360254T3 (en)
PE (1) PE20080057A1 (en)
TW (1) TWI400233B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
AU2003218660A1 (en) * 2002-02-13 2003-09-04 Glaxo Group Limited Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
TWI400233B (en) 2013-07-01
DE602007012071D1 (en) 2011-03-03
ES2360254T3 (en) 2011-06-02
CN101421243A (en) 2009-04-29
PE20080057A1 (en) 2008-03-10
TW200808727A (en) 2008-02-16
CN101421243B (en) 2012-05-30

Similar Documents

Publication Publication Date Title
EA201200318A1 (en) Heterocyclic oximes
EA201290078A1 (en) HETEROCYCLIC COMPOUNDS TO INHIBIT PASK
MY148258A (en) Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
PT2150530E (en) Substituted sulfonamide derivatives
UA109698C2 (en) AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE
NZ600210A (en) Substituted 4-aminocyclohexane derivatives
EA201200260A1 (en) HETEROCYCLIC HYDRAZONES AND THEIR APPLICATION FOR THE TREATMENT OF CANCER AND INFLAMMATION
MX2008013212A (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors.
UA104489C2 (en) Compounds for the treatment of dyslipidemia and related diseases
DOP2010000137A (en) 1,2,3-TRIAZOL DERIVATIVES AS INHIBITORS FROM ESTEAROIL-COENZIMA TO DESATURASA
UA101393C2 (en) COMPOSITIONS AND USE OF TRIAZOLE DERIVATIVES FOR TREATING β-AMYLOID DISEASES AND SYNUCLEINOPATHIES
EA201591957A1 (en) GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION
IN2012DN00953A (en)
UY30284A1 (en) APPROPRIATE ARYLOXYETHYLAMINE COMPOUNDS TO TREAT DISORDERS RESPONDING TO DOPAMINE D3 RECEPTOR MODULATION
ATE502008T1 (en) AMINOMETHYL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR
MX2009013482A (en) [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases.
EA200870223A1 (en) DERIVATIVES OF BENZOIZOINDOL FOR THE TREATMENT OF PAIN
SG10201809506TA (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
DE602005001918D1 (en) S-TENATOPRAZOLNATRIUM MONOHYDRATE SALT AND ITS USE IN THE FORM OF A PROTON PUMPING MASTER
ATE540922T1 (en) AMINOETHYL AROMATIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR
MY160005A (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
ATE496031T1 (en) ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIBLE TO MODULATION OF THE DOPAMINE D3 RECEPTOR
EA201070478A1 (en) DIPHENYL CARBONIC ACIDS AND THEIR DERIVATIVES
DOP2012000061A (en) USE OF INDOL DERIVATIVES AS ACTIVATORS OF NURR-1, FOR THE APPLICATION IN TREATMENTS OF DISEASES AS PARKINSON
TW200635575A (en) Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties